PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 7, 20260 citationsOpen Access

Endocrinopathies associated with immune checkpoint inhibitors: incidence, clinical presentation, and management

View Full Paper
ASAngeliki M. Stamatouli

Key Points

  • The aim is to explore the incidence and management of endocrinopathies associated with immune checkpoint inhibitors.
  • Review of literature on immune checkpoint inhibitors
  • Analysis of reported incidence of endocrinopathies
  • Evaluation of clinical management strategies
  • Highlight significant incidence rate of endocrinopathies
  • Emphasize variations in clinical presentation
  • Outline effective management strategies for these conditions

Abstract

This proceedings abstract is published in Colloquia Erudita – Volume 1: Proceedings of the 3rd International Babylon Conference on Clinical and Experimental Pharmacological Research (Hillah; June 29–30, 2026); a volume of proceedings edited by Rafal J. Al-Saigh, Argyro Kyriakaki, and Apostolos Zarros.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Angeliki M. Stamatouli (2026) studied this question.

synapsesocial.com/papers/69d49f44b33cc4c35a227c27https://doi.org/10.5281/zenodo.19426873
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patient with immune checkpoint inhibitor Pembrolizumab associated endocrine dysfunctions: a report of clinical case2024
  2. 2Autoimmune endocrinopathies associated with the use of immune checkpoint inhibitors: a clinical case of a combination of isolated secondary adrenal insufficiency and diabetes mellitus2024
  3. 3Do immune checkpoint inhibitor-related endocrinopathies affect survival rates in cancer patients? Presentation of two case reports2024
  4. 4An Individualized Approach in the Management of Thyroid Dysfunction Associated with Checkpoint Inhibitors – A Clinical Case Series2026
  5. 5Hypophysitis with adrenal insufficiency secondary to immune checkpoint inhibitors therapy2024